Catalent Biologics Content
-
UpTempoâ„ : Seamless Transitions From Bench To CGT Applications
6/19/2025
Accelerate cell and gene therapy development with high-yield, regulatory-compliant plasmid DNA manufacturing that shortens timelines, minimizes risks, and streamlines your supply chain.
-
Leveraging Advanced Tech, Proven Expertise From Cell Line Development And Beyond
1/28/2025
Learn how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.
-
Quantifying Cell Response With Duplex RT-qPCR
Discover a new potency bioassay using RT-qPCR to assess relative transcription activity, and learn more about the advantages and limitations of transcriptional assays versus reporter gene assays.